HUP0103761A3 - Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use - Google Patents

Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use

Info

Publication number
HUP0103761A3
HUP0103761A3 HU0103761A HUP0103761A HUP0103761A3 HU P0103761 A3 HUP0103761 A3 HU P0103761A3 HU 0103761 A HU0103761 A HU 0103761A HU P0103761 A HUP0103761 A HU P0103761A HU P0103761 A3 HUP0103761 A3 HU P0103761A3
Authority
HU
Hungary
Prior art keywords
hormone
cancer
compositions
independent
dependent
Prior art date
Application number
HU0103761A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HUP0103761A2 publication Critical patent/HUP0103761A2/hu
Publication of HUP0103761A3 publication Critical patent/HUP0103761A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0103761A 1998-10-08 1999-10-07 Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use HUP0103761A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28679398 1998-10-08
PCT/JP1999/005533 WO2000020034A1 (fr) 1998-10-08 1999-10-07 Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant

Publications (2)

Publication Number Publication Date
HUP0103761A2 HUP0103761A2 (hu) 2002-02-28
HUP0103761A3 true HUP0103761A3 (en) 2002-11-28

Family

ID=17709122

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103761A HUP0103761A3 (en) 1998-10-08 1999-10-07 Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use

Country Status (9)

Country Link
US (1) US20060135435A1 (hu)
EP (1) EP1136079A4 (hu)
KR (1) KR20010080007A (hu)
CN (1) CN1322139A (hu)
AU (1) AU6004999A (hu)
CA (1) CA2345213A1 (hu)
HU (1) HUP0103761A3 (hu)
NO (1) NO20011763L (hu)
WO (1) WO2000020034A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087616A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Remedes contre la recurrence postoperative du cancer du sein chez les femmes en premenopause
WO2002087619A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
WO2002087618A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
EP1444988A4 (en) 2001-11-13 2007-04-25 Takeda Pharmaceutical CANCER AGENT
WO2003075958A1 (fr) * 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle
CN1688527A (zh) 2002-08-12 2005-10-26 武田药品工业株式会社 稠合的苯衍生物以及用途
US8497691B2 (en) 2007-06-28 2013-07-30 Frymaster L.L.C. Oil quality sensor and adapter for deep fryers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CN1077107C (zh) * 1996-07-19 2002-01-02 武田药品工业株式会社 杂环化合物、其制备和用途
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
NZ517497A (en) * 1997-08-15 2004-11-26 Cephalon Inc The synergistic effect of tyrosine kinase inhibitors and chemical castration agents in the treatment of prostate cancer
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
EP1136079A4 (en) 2004-09-22
AU6004999A (en) 2000-04-26
WO2000020034A1 (fr) 2000-04-13
CA2345213A1 (en) 2000-04-13
US20060135435A1 (en) 2006-06-22
KR20010080007A (ko) 2001-08-22
NO20011763D0 (no) 2001-04-06
CN1322139A (zh) 2001-11-14
NO20011763L (no) 2001-06-07
HUP0103761A2 (hu) 2002-02-28
EP1136079A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
HK1039782A1 (en) Compositions and methods for wt1 specific immunotherapy
HUP0104717A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU3491001A (en) Compositions and methods for the early diagnosis of ovarian cancer
EP1257287A4 (en) COMPOSITIONS AND METHODS FOR THE EARLY DETECTION OF OVARIAN CANCER
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
EP0960191A4 (en) COMPOSITIONS AND METHODS FOR THE USE OF DEFENSIN
HUP0103562A3 (en) Novel compositions and use
EP1056456A4 (en) R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
HUP0103761A3 (en) Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use
GB2340936B (en) Improvements relating to the measurement of particle size distribution
EP0964686A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING OR DELAYING THE DEVELOPMENT OF ATHEROSCLERIC LESIONS
IL132094A0 (en) Methods and compositions for treatment of ovarian cancer
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
EP1207896A4 (en) METHOD AND COMPOSITIONS FOR REDUCING THE SERUM PHOSPHATE MIRROR
AU2342299A (en) Compositions and methods for detecting and treating breast cancer
GB2338234B (en) Preparation of finasteride
EP1243928A4 (en) MEANS FOR STABILIZING COMPOSITIONS AND REAGENTS
HUP0101602A3 (en) Fertility improving composition and application thereof
GB2336903B (en) Furnace lining measurement
HK1037139A1 (en) Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
GB2340937B (en) Improvements relating to the measurement of particle size distribution
PL342253A1 (en) Pharmacological compositions based on bibapticide for visualising and treating thrombuses
HK1044021A1 (zh) 用於治療和診斷卵巢癌的組合物和方法
PT969119E (pt) Disposição bem como método para o revestimento de objectos
PL342365A1 (en) Methods of and compositions for diagnosing hepatomas